Risks of PPIs: What’s Real, What Needs More Research

New studies have linked reflux medications to dementia and other diseases. Should you worry? A Michigan Medicine expert explains the science.

7:00 AM

Author | Rene Wisely

For more than 30 years, medications such as omeprazole (Prilosec), lansoprazole (Prevacid) and esomeprazole (Nexium) have been the go-to treatment for acid-related disorders of the digestive tract including gastroesophageal reflux disease (GERD) and peptic ulcer disease.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Called proton pump inhibitors (PPIs), an estimated 15 million Americans use them — both prescription and over-the-counter varieties.

While acid contributes to the breakdown and digestion of food, sometimes it eats away at the protective mucous barrier that lines the digestive organs, causing ulcers, and can lead to heartburn or regurgitation.

A PPI taken 30-60 minutes before a meal dramatically reduces the acid production of certain cells in the stomach, giving a chance for ulcers to heal and reduce reflux.

"PPIs really improve the quality of life of some patients," says Michigan Medicine's Jacob Kurlander, M.D., a clinical lecturer and gastroenterologist.

Questioning recent research

In the past couple of years, some studies have raised concern about possible adverse effects of long-term PPI use. It's a frightening list, including low magnesium, low vitamin D, stroke, Clostridium difficile (C. diff) infection, bone fractures, heart attacks, stomach cancer, pancreatic cancer, kidney disease and dementia.

SEE ALSO: Is It Safe to Take PPIs? A Gastroenterologist Explains the Risks

"Patients are coming to me with questions," Kurlander says. But worry about these drugs' risks shouldn't be automatic.

When such research is published, the medical community should pause and examine each study individually on its own merits, Kurlander says.

"What's interesting is there are often studies that go both ways, that PPIs may be either protective or harmful," he says. "The key is to look at the quality of the study." This has been the case with dementia, heart attacks and pneumonia.

A common shortcoming of studies showing adverse effects from PPIs is that they are often observational studies. Unlike randomized controlled trials, observational studies can have distorted conclusions because of difficulty accounting for certain unmeasured variables.

A person who is obese, for example, is at an increased risk for reflux because their gut pushes on their stomach, causing the acid to create heartburn. An obese person also is more likely to have cardiovascular disease, so that increases their risk for heart attacks. "Unless these confounders are carefully controlled for and measured in these studies, there is a possibility to find association between PPIs and heart attacks without true causation," Kurlander says.

That said, known risks of PPIs can rarely include flatulence, diarrhea, headache, abdominal pain and nausea.

Hearing both sides

Another issue? Patients don't often hear of follow-up studies, Kurlander says.

For example, an October 2017 study in Gastroenterology debunks a 2016 study in JAMA Neurology that implied that long-term PPI use could contribute to cognitive decline. It's a report that received a lot of traction in mainstream media, yet the new study did not garner the same attention.

"Even if you believe that some of these adverse effects are real, the size of the effects tend to be small," Kurlander says. "Studies suggest that the excess risk of getting a bone fracture from a PPI is on the order of 0.3 percent per year per person. While it is something, people who have GERD or a peptic ulcer frequently find going without PPIs bothersome, and in patients who need PPIs to prevent ulcers, going without a PPI could cause a morbid or disabling bleeding event."

Before PPIs, the solution for ulcers was ugly, Kurlander says. It was typically a grueling surgery that involved cutting nerves or a part of the stomach.

PPIs have helped so many people, even colleagues in his office still take them regularly, says Kurlander.

Finding solutions

One benefit to the controversy surrounding PPIs: It encourages physicians to be more mindful of prescribing them, Kurlander says. Physicians examine why the patient is taking them, what evidence exists to support the decision, and the patient's risk tolerance to any potential long-term effects.

Good old-fashioned clean living has made a comeback as a result as well. Some of Kurlander's patients have elected to alter their lifestyle choices, including losing weight, avoiding trigger foods and eating earlier before bedtime, to cut down on the need for PPIs.

To schedule an appointment to discuss PPIs or digestive issues, call 888-229-7408.


More Articles About:

Digestive Health Reflux or GERD Pharmacy Digestive (GI) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

The Care Ecosystem: Supporting People Living with Dementia and Their Families

Welcome back to Season 6 of Minding Memory! In this episode, Lauren & Matt speak with Dr. Katherine (Kate) Possin, who holds the John Douglas French Alzheimer’s Foundation Professorship at the University of California, San Francisco Fein Memory & Aging Center. Dr. Possin talks about the Care Ecosystem, a telephone and web-based model that provides ongoing education, support, care planning, and coordination for people living with dementia and their care partners. They’ll dig into how the Care Ecosystem was developed, and what studies have shown about its impact on people living with dementia.
team smiling together in front of 10 year anniversary sign
Health Lab

How gastroenterology nutrition therapy has evolved

At Michigan Medicine, physicians and nutritionists from the Division of Gastroenterology & Hepatology led the 10th annual “FOOD: The Main Course to Digestive Health” to educate nutritionists treating gastrointestinal diseases and conditions.
Portrait of Thomas Macek. He's wearing a navy blazer and light blue button-down shirt.
Philanthropy News

College of Pharmacy alum advances U-M Medical School addiction research

Grateful for support that help launched his career in pharmacology research and drug development, Tom Macek, Ph.D., has made a gift to the University of Michigan Medical School to advance addiction research.
bathroom toliets pattern and orange background
Health Lab

Got cyclosporiasis? How to take care of yourself and others

As the Cyclospora parasite outbreak sickens many, a primary care doctor’s top tips to get through it.
word statin in capital letters blue and pill out of silver case
Health Lab

More than half of U.S. adults now qualify for statins under new guidelines

Cholesterol-lowering medicines called statins can reduce heart attack and stroke risk decades later; a study finds millions more people should be taking them.
person holding scale with scrubs on and stethoscope
Health Lab

7 things to know about Medicare’s new GLP-1 coverage

Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.